Angiotension II Receptor Antagonists (БУ). Murray Epstein, Hans R. Brunner

The recent development of several new, non-peptide, orally active angiotensin II receptor antagonists is revolutionizing the treatment of patients with hypertension and various cardiovascular disorders. In this book experts review the current state of angiotensin II antagonists and survey the progress of these diverse applications. Issues relating to angiotensin II and their receptors are examined in relation to their effects on the kidney, non-diabetic renal disease, heart disease, diabetes mellitus, and various other disorders. The combination of AT1 receptor antagonists with other antihypertensive agents is reviewed in depth.
This book constitutes the only available compendium on the clinical and experimental
features of angiotensin II receptor antagonists.
The unique features of the rapidly emerging class of drugs are surveyed throughout.
Contributions have been made from international experts who have personally contributed to the discovery and development of these novel drugs.
Recent cutting-edge physiology and pharmacology studies by renowned international experts provide a platform for considering the clinical applications of these agents.